PROFILE is the first prospective, multi-national, observational, real-world study of Rekovelle in clinical practice, conducted in more than 940 women from 10 countries across Europe, North America and Australia. This study provides evidence of the effectiveness of Rekovelle across a broad range of patients in a real-world clinical setting and supports its efficacy and safety … [Read more…]

BURLINGAME, Calif.–(BUSINESS WIRE)–Innoviva, Inc. (Nasdaq: INVA) (“Innoviva”), a diversified holding company with a portfolio of royalties and other healthcare assets, today announced that the U.S. Food and Drug Administration’s (FDA) Antimicrobial Drugs Advisory Committee will convene April 17, 2023 to review data supporting the new drug application (NDA) for sulbactam-durlobactam (SUL-DUR). SUL-DUR is an investigational … [Read more…]

NASHVILLE, Tenn.–(BUSINESS WIRE)–HCA Healthcare, Inc. (NYSE:HCA), one of the nation’s leading healthcare providers, today announced that is has been recognized for the 13th time by Ethisphere, a global leader in defining and advancing standards of ethical business practices, as one of the 2023 World’s Most Ethical Companies. HCA Healthcare is one of only four honorees … [Read more…]

SAN FRANCISCO & LOS ANGELES & SAN DIEGO–(BUSINESS WIRE)–Biocom California, the association representing the life science industry of California, issued the following statement regarding the collapse of Silicon Valley Bank. The statement can be attributed to Joe Panetta, Biocom California’s president and CEO: “The collapse of Silicon Valley Bank (SVB) and upheaval in the banking … [Read more…]

Investor Conference Call to be held 9:00 a.m. Eastern Time ROCHESTER HILLS, Mich.–(BUSINESS WIRE)–InfuSystem Holdings, Inc. (NYSE American: INFU) (“InfuSystem” or the “Company”), a leading national health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers, announced today it will issue preliminary fourth quarter and full year 2022 financial … [Read more…]

Volume of new business demonstrates strong growth across key mobile health, medical transportation service lines NEW YORK–(BUSINESS WIRE)–DocGo (Nasdaq:DCGO), a leading provider of last-mile mobile health services, announced today that since the start of 2023 DocGo has had multiple new single and multi-year revenue contract wins as well as contract expansions valued at over $180 … [Read more…]

– Presentation to be webcast on www.exelixis.com – ALAMEDA, Calif.–(BUSINESS WIRE)–Exelixis, Inc. (Nasdaq: EXEL) today announced that company management will provide a corporate overview at the 2023 Guggenheim Healthy Altitudes Summit on Thursday, March 16, 2023 at 10:00 a.m. ET / 8:00 a.m. MT / 7:00 a.m. PT. To access the webcast link, log onto … [Read more…]

Transforms into new Life Sciences and Diagnostics company WALTHAM, Mass.–(BUSINESS WIRE)–PerkinElmer Inc. (NYSE: PKI), today announced that it has successfully completed the previously announced divestiture of its Applied, Food and Enterprise Services businesses to New Mountain Capital, a growth-oriented investment firm. The resulting new, high-growth Life Sciences and Diagnostics business, focused on developing and delivering … [Read more…]

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving quality of life for patients, today announced that it will report financial results for the third quarter of fiscal year 2023 before the market open … [Read more…]

MONTPELLIER, France–(BUSINESS WIRE)–Regulatory News: Sensorion (FR0012596468 – ALSEN) a pioneering clinical-stage biotechnology company which specializes in gene therapies in the ear, has learned that Silicon Valley Bank (SVB) has been closed by the California Department of Financial Protection and Innovation, which appointed the Federal Deposit Insurance Corporation (“FDIC”) as receiver. Sensorion does not expect any … [Read more…]